MENAT Platelet Rich Plasma (PRP) Tubes Market is expected to reach US$ 79.71 million by 2028

Publisher: The Insight Partners

Usage Segment to Lead MENAT Platelet Rich Plasma Tubes Market During 2022–2028

According to our latest study on "MENAT Platelet-Rich Plasma Tubes Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Usage, End User, and Volume," the MENAT platelet rich plasma tubes market was valued at US$ 27.26 million in 2021 and is projected to reach US$ 79.71 million by 2028; it is estimated to grow at a CAGR of 16.6% from 2022 to 2028. The market growth is primarily attributed to rising cosmetic and aesthetic procedures and increasing cases of sports injuries.

The COVID-19 pandemic had a positive impact on platelet rich plasma therapy. COVID-19 was a serious disease where patients rapidly developed respiratory diseases and multiple organ failure, resulting in death within a short time. Platelet rich plasma (PRP) therapy is a pioneering step toward fulfilling clinical needs as platelets are mainly active and function for supporting the fibrin matrix that is highly polymerized. Also, clinical studies reveal that PRP therapy proves effective during the early stage of the disease. However, platelet rich plasma therapy may not be useful if performed at a later stage of infection. Further, with the growing number of research and clinical trials related to platelet rich plasma therapy, there was an accelerating demand for PRP tubes, ultimately driving the MENAT platelet rich plasma tubes market growth during the forecast period.

MENAT Platelet Rich Plasma (PRP) Tubes Market, by Region 2021 (%)

To get free sample copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/sample/TIPRE00029791

Source: The Insight Partners Analysis

Based on usage, the MENAT platelet rich plasma tubes market is segmented into skin rejuvenation, hair restoration, orthopedics, surgical oncology, gynaecology, and others. The orthopedics segment held the largest share of the market in 2021. However, the skin rejuvenation segment is anticipated to register the highest CAGR of 17.4% in the market during the forecast period. The use of platelet rich plasma (PRP) is expanding to numerous medical fields, including orthopedic surgery and sports medicine. In recent years, platelet rich plasma has been widely used to treat orthopedic injuries-related diseases. It is most commonly used to treat orthopedic and sports injuries. PRP therapy is a form of regenerative medicine. Regenerative medicine centers on using the patient’s body tissue such as blood, fat, or bone marrow to heal the body. PRP has been used in operating rooms for several decades to help wound healing and stimulate bone formation in spinal fusion surgery. PRP has recently been used in outpatient settings to treat common overuse conditions, including achilles tendon, rotator cuff tendon, tennis elbow, patellar tendon, plantar fascia, hamstring tendon, and joint pain from arthritis or cartilage wear (particularly the knee).

Platelet rich plasma (PRP) is a promising noninvasive technique for facial rejuvenation. In recent years, despite the increase in facial rejuvenation cosmetic procedures, there has been a decrease in the number of patients opting for surgical facial rejuvenation procedures. This emphasizes the importance of noninvasive procedures in improving cosmetic outcomes. Among the noninvasive facial rejuvenation methods, platelet rich plasma, a platelet concentrate obtained from autologous plasma, has been used in various dermatological applications, including facial rejuvenation. Thus, the rising adoption of noninvasive procedures is promoting the MENAT platelet rich plasma tubes market growth.

Manso Medical Co Ltd, Lingen Precision Medical Products Co Ltd, Integrity PRP, Henso Medical (Hangzhou) Co Ltd, Emerging Medical Group LLC, Juventix Regenerative Medical LLC, and AdvaCare Pharma USA LLC are among the leading companies operating in the MENAT platelet rich plasma tubes market.

The report segments the MENAT platelet rich plasma tubes market as follows:

Based on usage, the MENAT platelet rich plasma tubes market is segmented into skin rejuvenation, hair restoration, orthopedics, surgical oncology, gynaecology, and others. Based on end user, the MENAT platelet rich plasma tubes market is segmented into medspa, dermatology office, hospitals and healthcare practices, tricologist and others. Based on volume, the MENAT platelet rich plasma tubes market is segmented into less than 5ml, 6ml to 10ml, and more than 10ml. By region, the MENAT platelet rich plasma tubes market is segmented into the UAE, Saudi Arabia, Algeria, Qatar, Morocco, Egypt, and the Rest of MENAT.

Contact Us
Contact Us: The Insight Partners 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com